Now more than ever it is important for pharmaceutical companies to put compliance as their number one priority. In this Q&A, Kristina Dolan, Director of Marketing at Ecos, interviews experienced freelance multi-channel marketing manager, Adi Borovick. Borovick dives into the implications oOriginal Article
You may also like
Ariane de Ganck
Jasper Therapeutics merges with Kira Pharmaceuticals
Lilly to acquire AtaiBeckley in deal worth $2.8bn
Camena Bioscience appoints Gregory McGuinness as CEO
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
